Brain-targeted intranasal delivery of biologics: a perspective for Alzheimer's disease treatment
Intranasal delivery offers a promising route to bypass the blood-brain barrier (BBB), enabling efficient brain targeting of biologics through diverse formulations and functional modifications.
Authors
- Beiyu Zhang (ORCID: https://orcid.org/0000-0002-6391-7903)
- Y. Li (ORCID: https://orcid.org/0000-0002-4854-5523)
- Peter Harvey (ORCID: https://orcid.org/0000-0001-5159-5313)
- Zheying Zhu (ORCID: https://orcid.org/0000-0002-2135-3812)
- Cameron Alexander (ORCID: https://orcid.org/0000-0001-8337-1875)
- Huan Li (ORCID: https://orcid.org/0009-0002-0263-515X)
- Xiaoxia Shen (ORCID: https://orcid.org/0009-0007-2112-0510)
Institutions
- University of Nottingham (GB)
Publication Details
- Journal
- RSC Pharmaceutics
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1039/d5pm00148j
- Citations
- 3
- Primary Topic
- Vagus Nerve Stimulation Research
- Type
- article
- Field-Weighted Citation Impact
- 2.53